UBE3A (Ubiquitin-protein ligase E3A) variants and mutations
UBE3A (also known as Ubiquitin-protein ligase E3A) is a human protein-coding gene encoding an ubiquitin-protein ligase E3A protein. Its ubiquitin-ligase activity controls turnover of selected neuronal proteins and is subject to maternal-specific expression in many neurons. Loss of the maternal allele causes Angelman syndrome, while increased dosage contributes to neurodevelopmental abnormalities in 15q11-q13 duplication. This analysis covers 481 UBE3A variants and mutations. Of these, 63% have computational variant effect predictions. Disease context includes Angelman syndrome, hereditary disease, and Intellectual disability. Example UBE3A variants include K3R, Q6P, and W9*.
Variant analysis overview
- Gene: UBE3A
- Protein: Ubiquitin-protein ligase E3A
- UniProt accession: Q05086
- Organism: Homo sapiens
- Variants analyzed: 481
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 233 unspecified-consequence records; 1 stop retained variant; 3 stop lost; 95 synonymous variants; 138 missense variants; 1 frameshift variants; 4 stop-gained variants; 1 in-frame deletions; 3 splice-region variants; 2 substitution
- Prediction scores: 305 variants have prediction scores (63% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Angelman syndrome, hereditary disease, Intellectual disability, neurodevelopmental disorder, Epileptic encephalopathy, Global developmental delay, Seizure, Abnormal corpus callosum morphology, Expressive language delay, Poor speech, EEG abnormality, keloid.
Protein structure and variant hotspots
- Protein features: 1 domains; 2 post-translational modification sites.
- Structural context: 110 variants have structural context.
- Experimental data: 57 protein positions have experimental scores. Source: binding assays.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable UBE3A variants
Examples include K3R, Q6P, W9*, G12V, E20V, R23Q, L32Q, I33M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- K3R (p.Lys3Arg), rs751766501, ClinGen CA7435748, ClinVar RCV001573760, CADD 23.00, Uncertain significance, not provided
- Q6P (p.Gln6Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- W9* (p.Trp9Ter), rs765727905, ClinGen CA7435744, ClinVar RCV001775356, CADD 24.40, Likely benign
- G12V (p.Gly12Val), rs864309506, Pathogenic
- E20V (p.Glu20Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R23Q (p.Arg23Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L32Q (p.Leu32Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I33M (p.Ile33Met), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- R35C (p.Arg35Cys), rs369572863, cosmic curated COSV99217, ESP rs369572863, AlphaMissense 0.99, MetaLR 0.14, Variant assessed as somatic; moderate impact.
- C44Y (p.Cys44Tyr), UniProt VAR 007852
- G45V (p.Gly45Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A48T (p.Ala48Thr), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, Variant assessed as somatic; moderate impact.
- T50P (p.Thr50Pro), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99216, Variant assessed as somatic; moderate impact.
- S56F (p.Ser56Phe), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, Variant assessed as somatic; moderate impact.
- R62C (p.Arg62Cys), rs587783098, ClinGen CA294634, cosmic curated COSV10457, ClinVar RCV000144764, AlphaMissense 0.46, MetaLR 0.16, Uncertain significance, not provided; Angelman syndrome
- R62H (p.Arg62His), rs587784511, ClinGen CA173802, NCI-TCGA Cosmic COSV5166, AlphaMissense 0.25, MetaLR 0.13, Uncertain significance, Angelman syndrome
- R62L (p.Arg62Leu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51660, Variant assessed as somatic; moderate impact.
- I70V (p.Ile70Val), rs587783146, ClinGen CA294734, NCI-TCGA Cosmic COSV5167, ClinVar RCV000144820, AlphaMissense 0.08, MetaLR 0.04, Uncertain significance, Angelman syndrome
- A72S (p.Ala72Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A72V (p.Ala72Val), NCI-TCGA Cosmic COSV5167, cosmic curated COSV51670, Uncertain significance, Angelman syndrome
- E74K (p.Glu74Lys), rs1207660411, ClinGen CA391356386, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51660, AlphaMissense 0.95, MetaLR 0.19, Uncertain significance, not provided
- A80T (p.Ala80Thr), rs2081077265, ClinGen CA391356343, ClinVar RCV003621374, ClinVar RCV006451419, AlphaMissense 0.86, MetaLR 0.32, Uncertain significance, not provided
- C83S (p.Cys83Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D84N (p.Asp84Asn), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- P85H (p.Pro85His), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- P85S (p.Pro85Ser), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- H86Y (p.His86Tyr), rs1452134414, ClinGen CA391356300, ClinVar RCV002005694, ClinVar RCV003313257, AlphaMissense 0.99, MetaLR 0.10, Uncertain significance, not provided; Angelman syndrome
- A103T (p.Ala103Thr), NCI-TCGA TCGA novel, Uncertain significance, not provided
- S107C (p.Ser107Cys), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99216, Variant assessed as somatic; moderate impact.
- C108T (p.Cys108Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K112N (p.Lys112Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R119I (p.Arg119Ile), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, Variant assessed as somatic; moderate impact.
- T129K (p.Thr129Lys), rs587781241, ClinGen CA333390, NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, AlphaMissense 0.90, MetaLR 0.07, Pathogenic, Angelman syndrome
- E131G (p.Glu131Gly), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51662, Variant assessed as somatic; moderate impact.
- I136M (p.Ile136Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I136T (p.Ile136Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L137I (p.Leu137Ile), rs566793027, ClinGen CA7435630, ClinVar RCV001227497, 1000Genomes rs566793027, AlphaMissense 0.22, MetaLR 0.03, Uncertain significance, Angelman syndrome
- C140R (p.Cys140Arg), rs587782907, ClinGen CA333406, ClinVar RCV000144323, ClinVar RCV000483509, AlphaMissense 1.00, MetaLR 0.15, Uncertain significance, Angelman syndrome
- E142K (p.Glu142Lys), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51669, Uncertain significance, UBE3A-related disorder
- E144* (p.Glu144Ter), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51663, Variant assessed as somatic; high impact.
- L149F (p.Leu149Phe), NCI-TCGA TCGA novel, Uncertain significance, Angelman syndrome
- R151C (p.Arg151Cys), rs587783101, ClinGen CA294646, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51669, AlphaMissense 0.96, MetaLR 0.15, Uncertain significance, Angelman syndrome
- R155S (p.Arg155Ser), cosmic curated COSV10802, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V156G (p.Val156Gly), rs587782915, ClinGen CA333422, ClinVar RCV000144335, ClinVar RCV004791276, AlphaMissense 0.96, MetaLR 0.12, Uncertain significance, not provided; Angelman syndrome
- S158L (p.Ser158Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L163S (p.Leu163Ser), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51665, Variant assessed as somatic; moderate impact.
- S166R (p.Ser166Arg), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51660, Uncertain significance, not specified
- E177K (p.Glu177Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L181F (p.Leu181Phe), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- D185Y (p.Asp185Tyr), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- D187E (p.Asp187Glu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, Variant assessed as somatic; moderate impact.
- D189N (p.Asp189Asn), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, Variant assessed as somatic; moderate impact.
- E192A (p.Glu192Ala), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51667, Variant assessed as somatic; moderate impact.
- E192K (p.Glu192Lys), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51663, TOPMed rs2080302503, Variant assessed as somatic; moderate impact.
- A196S (p.Ala196Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S199Y (p.Ser199Tyr), NCI-TCGA Cosmic COSV5166, Variant assessed as somatic; moderate impact.
- A201T (p.Ala201Thr), rs147145506, ClinGen CA213368, cosmic curated COSV10722, ClinVar RCV000082351, AlphaMissense 0.09, MetaLR 0.02, Benign/Likely benign, Inborn genetic diseases; not specified; not provided
- E205K (p.Glu205Lys), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, CADD 19.30, Variant assessed as somatic; moderate impact.
- N222S (p.Asn222Ser), rs2552191752, ClinGen CA391355365, ClinVar RCV003620731, NCI-TCGA TCGA novel, Uncertain significance, Angelman syndrome
- N223K (p.Asn223Lys), NCI-TCGA Cosmic COSV5167, cosmic curated COSV51671, Variant assessed as somatic; moderate impact.
- Q225* (p.Gln225Ter), NCI-TCGA Cosmic COSV5167, cosmic curated COSV51671, Variant assessed as somatic; high impact.
- L227F (p.Leu227Phe), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, Variant assessed as somatic; moderate impact.
- P229L (p.Pro229Leu), NCI-TCGA Cosmic COSV9921, Variant assessed as somatic; moderate impact.
- D231G (p.Asp231Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D235V (p.Asp235Val), rs587780581, ClinGen CA333481, ClinVar RCV000144555, UniProt VAR 073199, AlphaMissense 0.98, MetaLR 0.18, Pathogenic, Angelman syndrome
- A238P (p.Ala238Pro), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- I239V (p.Ile239Val), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51669, Variant assessed as somatic; moderate impact.
- R240K (p.Arg240Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L247R (p.Leu247Arg), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- K251N (p.Lys251Asn), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Uncertain significance, not provided
- I252N (p.Ile252Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L260H (p.Leu260His), rs587780582, ClinGen CA333393, ClinVar RCV000144318, UniProt VAR 073200, AlphaMissense 1.00, MetaLR 0.19, Likely pathogenic, Angelman syndrome
- L260Q (p.Leu260Gln), UniProt VAR 073201, Uncertain significance, in AS
- V267M (p.Val267Met), rs745363984, ClinGen CA7435588, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, AlphaMissense 0.65, MetaLR 0.03, Conflicting interpretations, not provided; Angelman syndrome; Inborn genetic diseases
- H274D (p.His274Asp), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- R279* (p.Arg279Ter), rs997044541, ClinGen CA391354988, NCI-TCGA Cosmic COSV5166, ClinVar RCV000989275, Pathogenic
- R279G (p.Arg279Gly), NCI-TCGA Cosmic COSV5166, Variant assessed as somatic; moderate impact.
- R279Q (p.Arg279Gln), rs200496882, ClinGen CA7435585, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51663, AlphaMissense 0.11, MetaLR 0.03, Uncertain significance, Angelman syndrome
- P281S (p.Pro281Ser), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51665, Variant assessed as somatic; moderate impact.
- L286W (p.Leu286Trp), rs587780583, ClinGen CA333487, ClinVar RCV000144557, UniProt VAR 073202, AlphaMissense 0.97, MetaLR 0.09, Pathogenic, Angelman syndrome
- V290G (p.Val290Gly), rs1059383, UniProt VAR 047516, Ensembl rs1059383, AlphaMissense 0.94, MetaLR 0.12
- V290I (p.Val290Ile), rs1064794579, ClinGen CA16619910, ClinVar RCV000486907, ClinVar RCV000695593, AlphaMissense 0.12, MetaLR 0.03, Uncertain significance, Angelman syndrome
- N293T (p.Asn293Thr), rs587782908, ClinGen CA333409, ClinVar RCV000144324, UniProt VAR 073203, AlphaMissense 0.94, MetaLR 0.08, Uncertain significance, Angelman syndrome
- S298G (p.Ser298Gly), rs1595810000, ClinGen CA391354857, NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, AlphaMissense 0.78, MetaLR 0.13, Uncertain significance, Angelman syndrome
- E303K (p.Glu303Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A305T (p.Ala305Thr), cosmic curated COSV10722, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A312V (p.Ala312Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K315N (p.Lys315Asn), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51667, Variant assessed as somatic; moderate impact.
- P317L (p.Pro317Leu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51665, Variant assessed as somatic; moderate impact.
- Q335H (p.Gln335His), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51665, Variant assessed as somatic; moderate impact.
- R337Q (p.Arg337Gln), rs1384065874, ClinGen CA391354589, ClinVar RCV003509951, ClinVar RCV004676234, AlphaMissense 0.14, MetaLR 0.08, Uncertain significance, Inborn genetic diseases; Angelman syndrome
- R337W (p.Arg337Trp), NCI-TCGA TCGA novel, Likely pathogenic, Angelman syndrome
- Q344R (p.Gln344Arg), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- I347L (p.Ile347Leu), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- K350E (p.Lys350Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E355D (p.Glu355Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E355K (p.Glu355Lys), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51667, Variant assessed as somatic; moderate impact.
- F356Y (p.Phe356Tyr), NCI-TCGA Cosmic COSV5166, NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- S358T (p.Ser358Thr), rs141984760, ClinGen CA333425, ClinVar RCV000144337, ClinVar RCV000488159, AlphaMissense 0.10, MetaLR 0.03, Benign, Angelman syndrome
- R359* (p.Arg359Ter), rs2080238010, ClinGen CA391354435, NCI-TCGA Cosmic COSV5166, ClinVar RCV001071345, Pathogenic
- R359L (p.Arg359Leu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, Variant assessed as somatic; moderate impact.
- R359Q (p.Arg359Gln), rs780050034, ClinGen CA7435565, NCI-TCGA Cosmic COSV5166, AlphaMissense 0.14, MetaLR 0.03, Uncertain significance, Inborn genetic diseases; Angelman syndrome
- D365E (p.Asp365Glu), rs375600705, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, ESP rs375600705, AlphaMissense 0.77, MetaLR 0.31, Likely benign
- I368V (p.Ile368Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V369F (p.Val369Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S372L (p.Ser372Leu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, TOPMed rs2080233700, gnomAD rs2080233700, Variant assessed as somatic; moderate impact.
- S372P (p.Ser372Pro), UniProt VAR 008143
- C374Y (p.Cys374Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N382H (p.Asn382His), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- V384L (p.Val384Leu), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- E394K (p.Glu394Lys), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- D396N (p.Asp396Asn), rs1194662343, NCI-TCGA Cosmic COSV5167, TOPMed rs1194662343, AlphaMissense 0.10, MetaLR 0.31, Variant assessed as somatic; moderate impact.
- D396Y (p.Asp396Tyr), NCI-TCGA Cosmic COSV5167, cosmic curated COSV51670, Variant assessed as somatic; moderate impact.
- D397G (p.Asp397Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D397Y (p.Asp397Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P402A (p.Pro402Ala), NCI-TCGA Cosmic COSV9921, Variant assessed as somatic; moderate impact.
- P402H (p.Pro402His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L412R (p.Leu412Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E416* (p.Glu416Ter), rs886043612, ClinGen CA10605727, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, Pathogenic
- N419S (p.Asn419Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K420R (p.Lys420Arg), rs781211197, ExAC rs781211197, gnomAD rs781211197, AlphaMissense 0.09, MetaLR 0.21, Variant assessed as somatic; moderate impact.
- G422D (p.Gly422Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P423L (p.Pro423Leu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51663, Variant assessed as somatic; moderate impact.
- P423S (p.Pro423Ser), NCI-TCGA Cosmic COSV5167, cosmic curated COSV51670, Variant assessed as somatic; moderate impact.
- R424Q (p.Arg424Gln), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, Variant assessed as somatic; moderate impact.
- P427L (p.Pro427Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E431K (p.Glu431Lys), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51662, TOPMed rs2080204750, Variant assessed as somatic; moderate impact.
- R440Q (p.Arg440Gln), rs765813410, ClinGen CA7435542, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51667, AlphaMissense 0.13, MetaLR 0.45, Uncertain significance, Angelman syndrome
- P445H (p.Pro445His), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- E448* (p.Glu448Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L458P (p.Leu458Pro), rs587781242, ClinGen CA333396, ClinVar RCV000144319, UniProt VAR 073205, AlphaMissense 1.00, MetaLR 0.51, Likely pathogenic, Angelman syndrome
- E459* (p.Glu459Ter), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51665, Variant assessed as somatic; high impact.
- E459Q (p.Glu459Gln), NCI-TCGA Cosmic COSV5166, Variant assessed as somatic; moderate impact.
- F467S (p.Phe467Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E472D (p.Glu472Asp), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, Variant assessed as somatic; moderate impact.
- M478V (p.Met478Val), rs864309507, Uncertain significance
- P481L (p.Pro481Leu), rs587780584, ClinGen CA333490, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, AlphaMissense 0.98, MetaLR 0.62, Pathogenic, Angelman syndrome
- A486D (p.Ala486Asp), NCI-TCGA Cosmic COSV9921, Variant assessed as somatic; moderate impact.
- L491F (p.Leu491Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G492V (p.Gly492Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y495H (p.Tyr495His), rs2152820213, ClinGen CA391353512, ClinVar RCV001840865, NCI-TCGA TCGA novel, AlphaMissense 0.99, MetaLR 0.54, Uncertain significance, not provided
- R500C (p.Arg500Cys), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, Uncertain significance, in AS
- R500H (p.Arg500His), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, Uncertain significance, in AS
- R500P (p.Arg500Pro), rs587781243, ClinGen CA333399, ClinVar RCV000144320, UniProt VAR 073207, AlphaMissense 1.00, MetaLR 0.68, Likely pathogenic, Angelman syndrome
- M501I (p.Met501Ile), rs587782916, ClinGen CA333428, ClinVar RCV000144340, UniProt VAR 073208, AlphaMissense 1.00, MetaLR 0.74, Uncertain significance, Angelman syndrome
- Y502C (p.Tyr502Cys), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99216, Variant assessed as somatic; moderate impact.
- R506I (p.Arg506Ile), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, Variant assessed as somatic; moderate impact.
- I507L (p.Ile507Leu), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51662, Variant assessed as somatic; moderate impact.
- T508I (p.Thr508Ile), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51664, Variant assessed as somatic; moderate impact.
- Q515* (p.Gln515Ter), NCI-TCGA Cosmic COSV9921, Variant assessed as somatic; high impact.
- Q515E (p.Gln515Glu), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99216, Variant assessed as somatic; moderate impact.
- Q515H (p.Gln515His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q518* (p.Gln518Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L519F (p.Leu519Phe), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51661, NCI-TCGA Cosmic COSV5167, Variant assessed as somatic; moderate impact.
- K526T (p.Lys526Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D530G (p.Asp530Gly), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51668, Variant assessed as somatic; moderate impact.
- V538F (p.Val538Phe), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51665, Variant assessed as somatic; moderate impact.
- A544T (p.Ala544Thr), rs755392575, ClinGen CA7435506, NCI-TCGA Cosmic COSV5166, cosmic curated COSV51662, AlphaMissense 0.69, MetaLR 0.54, Uncertain significance, not provided
- D550N (p.Asp550Asn), NCI-TCGA Cosmic COSV5166, Variant assessed as somatic; moderate impact.
- D550Y (p.Asp550Tyr), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51666, Variant assessed as somatic; moderate impact.
- L551S (p.Leu551Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D566H (p.Asp566His), NCI-TCGA Cosmic COSV9921, Variant assessed as somatic; moderate impact.
- D566N (p.Asp566Asn), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99217, Variant assessed as somatic; moderate impact.
- G568R (p.Gly568Arg), rs587781233, ClinGen CA333366, ClinVar RCV000144309, ClinVar RCV000622521, AlphaMissense 1.00, MetaLR 0.93, Likely pathogenic, Inborn genetic diseases
- E573* (p.Glu573Ter), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51663, Variant assessed as somatic; high impact.
- V579L (p.Val579Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I582M (p.Ile582Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N584S (p.Asn584Ser), rs587784517, ClinGen CA333531, ClinVar RCV000147869, Ensembl rs587784517, AlphaMissense 0.23, MetaLR 0.69, Uncertain significance, Angelman syndrome
- G588G (p.Gly588Gly), gnomAD 15-25356895-A-T, CADD 13.10
- M589I (p.Met589Ile), NCI-TCGA Cosmic COSV5166, cosmic curated COSV51667, Uncertain significance, in AS
- M589K (p.Met589Lys), rs587781244, ClinGen CA213383, ClinVar RCV000201268, UniProt VAR 073210, AlphaMissense 1.00, MetaLR 0.51, Likely pathogenic, Angelman syndrome
- F590F (p.Phe590Phe), gnomAD 15-25356889-G-A, CADD 10.20
- T591T (p.Thr591Thr), rs770078054, gnomAD 15-25356886-T-A, CADD 7.39
- Y592Y (p.Tyr592Tyr), rs139082033, gnomAD 15-25356883-G-A, CADD 5.05
- D593N (p.Asp593Asn), NCI-TCGA Cosmic COSV9921, cosmic curated COSV99216, Variant assessed as somatic; moderate impact.
- D593D (p.Asp593Asp), rs781556374, gnomAD 15-25356880-A-G, CADD 8.60
- E594E (p.Glu594Glu), rs34670662, gnomAD 15-25356877-T-C, CADD 8.63
- E594Q (p.Glu594Gln), rs757922956, gnomAD 15-25356879-C-G, CADD 22.40, PolyPhen-2 0.26
- E594* (p.Glu594Ter), gnomAD 15-25356879-C-A, CADD 41.00
- S595P (p.Ser595Pro), rs778513573, gnomAD 15-25356876-A-G, CADD 21.20, PolyPhen-2 0.01
Public UBE3A analysis runs
- UBE3A analysis run — UBE3A (481 variants) — completed 2026-08-18